Skip navigation
Don't pull Avandia from market, FDA panel urges
The controversial diabetes drug Avandia should stay on the market for now, with relaxed restrictions on its use, Food and Drug Administration advisers said on Thursday. Avandia was the world’s No. 1 diabetes drug until research showed in could raise heart risks. Full story
More diabetes news
FDA panel revisits Avandia diabetes drug
Low levels of melatonin linked to diabetes
2 million blood glucose meters recalled worldwide
Sugary drinks tied to 180,000 deaths worldwide
High-glycemic foods tied to diabetes risk
FDA panel backs novel diabetes pill from J&J
Test strip availability leads to better diabetes care
Vision loss tied to diabetes on rise in U.S.
Big rise in diabetes, especially down South
'High' diabetes rates found in UK ethnic groups
High 'normal' blood sugar may still harm brain
Type 2 diabetes linked to common virus
Like curry? It could help cut your diabetes risk
Ancient diet offers clues to diabetes
Diabetes drug may someday repair Alzheimer's damage
Paula Deen drops 30 pounds, feels 'a thousand times better'
Out-of-whack sleep habits can cause diabetes
Blueberries and apples tied to lower diabetes risk
Diabetics should lift weights before cardio
Cholesterol drugs get new warning labels
Diabetes amputations dramatically decrease
Paula Deen pledges money to diabetes association
Statins linked with small diabetes risk
  Link between cholesterol-lowering drugs and diabetes
Indian tribe turns to tradition to fight diabetes
  Alert dog a savior for 5-year-old diabetic
Boost your 'good fats' to help fend off diabetes
FDA offers new guidance for artificial pancreas
522 million people could have diabetes by 2030
New diabetes device tests tears instead of blood
Hidden shame of diabetes: 'I didn't speak about it'
'Muffin test' could help diagnose diabetes
BPA may be tied to diabetes, after all
Living in poor neighborhood can hurt health
advertisement


Advertise | AdChoices

Sponsored links

Resource guide